Diseases & Conditions
South Korea back in stem cell spotlight with new treatment (Reuters)
Reuters - More than five years after South Korea's scientific reputation was shattered by a cloning research scandal, the country has approved stem cell medication in the form of a treatment for heart attack victims for the world's first clinical use.
Study: Medicaid does make a difference after all (AP)
AP - Signing up for Medicaid could improve your overall health and financial security, says a surprising new study that offers clues on how President Barack Obama's health care overhaul might affect millions of low-income uninsured Americans.
Massage Beats Meds for Lower Back Pain, Study Says (HealthDay)
HealthDay - TUESDAY, July 5 (HealthDay News) -- Massage therapy may be better than
medication or exercise for easing low back pain in the short term, a new
government-funded study suggests.
Russian police search Novartis, Teva offices: report (Reuters)
Reuters - Russian police searched the offices of four pharmaceutical companies in Moscow on Tuesday, including Swiss drug maker Novartis AG and Israel-based Teva, the business daily Vedomosti reported, quoting a police source.
Arizona to start partial Medicaid freeze (AP)
AP - Federal officials cleared the way Friday for Arizona to bar thousands of low-income residents from seeking Medicaid coverage in the next year as the state tries to close a budget shortfall projected at roughly $1 billion.
Dutch may label some cannabis as a hard drug (Reuters)
Reuters - The Netherlands, famous for its liberal soft drugs policies, said on Friday it may label some highly concentrated forms of cannabis as a hard drug on a par with cocaine or heroin, because of the risk of addiction.
Kidney improvement sustained by Abbott drug: study (Reuters)
Reuters - Diabetics with moderate to severe chronic kidney disease showed significant and sustained improvement in kidney function through 52 weeks of treatment with a novel drug being developed by Abbott Laboratories, according to data from a midstage clinical trial.
Supreme Court rejects generic drug labeling suits (Reuters)
Reuters - The Supreme Court ruled on Thursday that generic drug companies cannot be sued under state law over allegations that they failed to provide adequate label warnings about potential side effects.
Supreme Court strikes down state drug data-mining law (Reuters)
Reuters - The Supreme Court struck down a law that prohibits the use of prescription drug records for marketing, ruling for free-speech rights over a state government's medical privacy concerns.
Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk (HealthDay)
HealthDay - TUESDAY, June 21 (HealthDay News) -- Some medications commonly
used to treat rheumatoid arthritis and psoriasis may help patients with
these autoimmune disorders lower their risk of developing diabetes,
researchers say.
Shire drug for rare swelling worked in trial: FDA (Reuters)
Reuters - Shire Plc's drug to treat severe swelling caused by a rare genetic disorder showed effectiveness in a key clinical trial, U.S. Food and Drug Administration staff said on Tuesday.
Study: Most Addicts Get Painkillers from Friends or Family, Not Doctors (Time.com)
Time.com - Only 1 in 5 people who misuse opioid painkillers like Vicodin get their drugs exclusively from doctors
Study Finds Botox Alternative Better at Smoothing 'Crow's Feet' (HealthDay)
HealthDay - MONDAY, June 20 (HealthDay News) -- A more recently approved
version of botulinum toxin type A beat the anti-wrinkle medication Botox
in a trial that compared the respective powers of each in erasing those
unwanted lines of aging around the eyes known as "crow's feet."
Millions Don't Get Meds for Serious Artery Disease: Study (HealthDay)
HealthDay - MONDAY, June 20 (HealthDay News) -- Millions of Americans suffer
from a condition known as peripheral artery disease but aren't receiving
medical treatment, putting them at risk of potentially fatal heart
problems, a new study finds.
Single Reading Can't Gauge Blood Pressure Control: Study (HealthDay)
HealthDay - MONDAY, June 20 (HealthDay News) -- Evaluating how well a person
responds to medication meant to lower blood pressure requires multiple
readings, new research suggests.
Indiana Planned Parenthood to drop Medicaid patients (Reuters)
Reuters - Planned Parenthood of Indiana will stop seeing Medicaid patients after Monday because of an Indiana law that cut the provider's funding.
Page 8 of 26



Diseases & Conditions


